2021 Cross-Border Healthcare Innovation & Partnership Summit (MSQ Ventures & Bayhelix)
We are excited to share with you that MSQ Ventures is hosting its 2021 Cross-Border Healthcare Innovation & Partnership Summit, on Jan 28th. Our partner BayHelix Group is a non-profit organization that connects emerging biopharmaceutical companies in China, with over 800 members globally and over two-thirds of members are C-level executives.
According to Shanghai Disease Control and Prevention requirements, because of the newly found community-spread COVID-19 cases in Shanghai on Jan 21st, our in-person 2021 Cross-Border Healthcare Innovation & Partnership Summit on Jan 28th has changed to Virtual Summit.
Agenda: Jan 28th Eastern Time (ET)
7:00 AM - 7:05 AM Opening Speech
7:05 AM - 8:00 AM Company Presentation
For detailed company introductions, please visit http://msqventures.com/2021-presentation
Alligator Bioscience
American Gene Technology
Chimeric Therapeutics
Crinetics Pharma
Igia Pharmaceuticals
Imugene
ISOThrive
Navitas Pharma
SCM Lifescience
8:00 AM - 8:45 AM Panel Discussion
"Global Biopharma Collaboration Opportunities and Challenges in 2021"
Moderator: Echo-Hindle Yang, Founder & CEO, MSQ Ventures
Panelists:
Juho Jalkanen, Chief Development Officer, Faron Pharmaceuticals
Alvin Luk, CEO, Neurophth Therapeutics
8:45 AM - 9:00 AM Company Presentation and Closing Remarks
How to Watch
To join us for this important event, Click here to register at no cost.
Once registered, you will receive your Zoom login.
Please contact yhe@msqventures.com with any questions.